Related Experiment Videos
Results of endoscopic third ventriculostomy
Mark R Iantosca1, Walter J Hader, James M Drake
1Connecticut Children's Medical Center, 100 Retreat Avenue, Suite 705, Hartford, CT 06106-2565, USA. miantos@ccmckids.org
Neurosurgery Clinics of North America
|April 6, 2004
Summary
Endoscopic third ventriculostomy (ETV) is a leading treatment for aqueductal stenosis. Further research is needed to compare ETV with shunting and refine techniques for optimal hydrocephalus management.
Area of Science:
- Neurosurgery
- Pediatric Neurosurgery
- Hydrocephalus Research
Background:
- Aqueductal stenosis is a significant cause of hydrocephalus.
- Endoscopic third ventriculostomy (ETV) is increasingly recognized as a primary treatment modality.
- ETV is effective for various etiologies including anatomic, inflammatory, and neoplastic causes.
Purpose of the Study:
- To evaluate the long-term efficacy of ETV compared to traditional shunting procedures.
- To establish clear indications for ETV in patients with intermediate response rates.
- To explore advancements in pre-operative and post-operative assessment of ETV outcomes.
Main Methods:
- Review of existing literature on ETV for aqueductal stenosis.
- Analysis of long-term outcomes for ETV versus shunting.
- Discussion of potential new diagnostic and monitoring techniques.
Main Results:
- ETV demonstrates significant utility in treating aqueductal stenosis across diverse etiologies.
- The technique is also valuable for pathological diagnosis and concurrent treatment.
- Further comparative studies and refined assessment methods are essential.
Conclusions:
- ETV is a promising treatment for aqueductal stenosis, with potential for broader applications in hydrocephalus management.
- Long-term comparative data and improved assessment tools are crucial for optimizing patient selection and outcomes.
- Continued technical refinement and research are necessary to fully define the role of ETV in neurosurgery.